These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25437816)

  • 1. Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom Study.
    Burisch J; Vardi H; Pedersen N; Brinar M; Cukovic-Cavka S; Kaimakliotis I; Duricova D; Bortlik M; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Krabbe S; Andersen V; Dahlerup JF; Kjeldsen J; Salupere R; Olsen J; Nielsen KR; Manninen P; Collin P; Katsanos KH; Tsianos EV; Ladefoged K; Lakatos L; Bailey Y; OʼMorain C; Schwartz D; Lupinacci G; De Padova A; Jonaitis L; Kupcinskas L; Turcan S; Barros L; Magro F; Lazar D; Goldis A; Nikulina I; Belousova E; Fernandez A; Pineda JR; Almer S; Halfvarson J; Tsai HH; Sebastian S; Friger M; Greenberg D; Lakatos PL; Langholz E; Odes S; Munkholm P;
    Inflamm Bowel Dis; 2015 Jan; 21(1):121-31. PubMed ID: 25437816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study.
    Burisch J; Vardi H; Schwartz D; Friger M; Kiudelis G; Kupčinskas J; Fumery M; Gower-Rousseau C; Lakatos L; Lakatos PL; D'Incà R; Sartini A; Valpiani D; Giannotta M; Arebi N; Duricova D; Bortlik M; Chetcuti Zammit S; Ellul P; Pedersen N; Kjeldsen J; Midjord JMM; Nielsen KR; Winther Andersen K; Andersen V; Katsanos KH; Christodoulou DK; Domislovic V; Krznaric Z; Sebastian S; Oksanen P; Collin P; Barros L; Magro F; Salupere R; Kievit HAL; Goldis A; Kaimakliotis IP; Dahlerup JF; Eriksson C; Halfvarson J; Fernandez A; Hernandez V; Turcan S; Belousova E; Langholz E; Munkholm P; Odes S;
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):454-464. PubMed ID: 32061322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment Steps, Surgery, and Hospitalization Rates During the First Year of Follow-up in Patients with Inflammatory Bowel Diseases from the 2011 ECCO-Epicom Inception Cohort.
    Vegh Z; Burisch J; Pedersen N; Kaimakliotis I; Duricova D; Bortlik M; Vinding KK; Avnstrøm S; Olsen J; Nielsen KR; Katsanos KH; Tsianos EV; Lakatos L; Schwartz D; Odes S; D'Incà R; Beltrami M; Kiudelis G; Kupcinskap L; Jucov A; Turcan S; Barros LF; Magro F; Lazar D; Goldis A; de Castro L; Hernandez V; Niewiadomski O; Bell S; Langholz E; Munkholm P; Lakatos PL;
    J Crohns Colitis; 2015 Sep; 9(9):747-53. PubMed ID: 26055976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohort.
    Burisch J; Pedersen N; Cukovic-Cavka S; Turk N; Kaimakliotis I; Duricova D; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Krabbe S; Andersen V; Dahlerup Jens F; Kjeldsen J; Salupere R; Olsen J; Nielsen KR; Manninen P; Collin P; Katsanos KH; Tsianos EV; Ladefoged K; Lakatos L; Bailey Y; O'Morain C; Schwartz D; Odes S; Martinato M; Lombardini S; Jonaitis L; Kupcinskas L; Turcan S; Barros L; Magro F; Lazar D; Goldis A; Nikulina I; Belousova E; Fernandez A; Hernandez V; Almer S; Zhulina Y; Halfvarson J; Tsai HH; Sebastian S; Lakatos PL; Langholz E; Munkholm P;
    Inflamm Bowel Dis; 2014 Jan; 20(1):36-46. PubMed ID: 24252978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with inflammatory bowel disease--an ECCO-EpiCom study.
    Burisch J; Weimers P; Pedersen N; Cukovic-Cavka S; Vucelic B; Kaimakliotis I; Duricova D; Bortlik M; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Krabbe S; Andersen V; Dahlerup JF; Kjeldsen J; Salupere R; Olsen J; Nielsen KR; Manninen P; Collin P; Katsanos KH; Tsianos EV; Ladefoged K; Lakatos L; Ragnarsson G; Björnsson E; Bailey Y; O'Morain C; Schwartz D; Odes S; Valpiani D; Boni MC; Jonaitis L; Kupcinskas L; Turcan S; Barros L; Magro F; Lazar D; Goldis A; Nikulina I; Belousova E; Fernandez A; Sanroman L; Almer S; Zhulina Y; Halfvarson J; Arebi N; Diggory T; Sebastian S; Lakatos PL; Langholz E; Munkholm P;
    J Crohns Colitis; 2014 Sep; 8(9):1030-42. PubMed ID: 24560877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.
    Burisch J; Pedersen N; Čuković-Čavka S; Brinar M; Kaimakliotis I; Duricova D; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Andersen V; Krabbe S; Dahlerup JF; Salupere R; Nielsen KR; Olsen J; Manninen P; Collin P; Tsianos EV; Katsanos KH; Ladefoged K; Lakatos L; Björnsson E; Ragnarsson G; Bailey Y; Odes S; Schwartz D; Martinato M; Lupinacci G; Milla M; De Padova A; D'Incà R; Beltrami M; Kupcinskas L; Kiudelis G; Turcan S; Tighineanu O; Mihu I; Magro F; Barros LF; Goldis A; Lazar D; Belousova E; Nikulina I; Hernandez V; Martinez-Ares D; Almer S; Zhulina Y; Halfvarson J; Arebi N; Sebastian S; Lakatos PL; Langholz E; Munkholm P;
    Gut; 2014 Apr; 63(4):588-97. PubMed ID: 23604131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort.
    Vegh Z; Burisch J; Pedersen N; Kaimakliotis I; Duricova D; Bortlik M; Avnstrøm S; Vinding KK; Olsen J; Nielsen KR; Katsanos KH; Tsianos EV; Lakatos L; Schwartz D; Odes S; Lupinacci G; De Padova A; Jonaitis L; Kupcinskas L; Turcan S; Tighineanu O; Mihu I; Barros LF; Magro F; Lazar D; Goldis A; Fernandez A; Hernandez V; Niewiadomski O; Bell S; Langholz E; Munkholm P; Lakatos PL;
    J Crohns Colitis; 2014 Nov; 8(11):1506-15. PubMed ID: 24998983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis.
    Mak LY; Ng SC; Wong IOL; Li MKK; Lo FH; Wong MTL; Leung CM; Tsang SWC; Chan KH; Sze SF; Shan EHS; Lam BCY; Hui AJ; Hung IFN; Leung WK
    J Gastroenterol Hepatol; 2018 Jan; 33(1):141-149. PubMed ID: 28475813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation.
    Odes S; Vardi H; Friger M; Wolters F; Russel MG; Riis L; Munkholm P; Politi P; Tsianos E; Clofent J; Vermeire S; Monteiro E; Mouzas I; Fornaciari G; Sijbrandij J; Limonard C; Van Zeijl G; O'morain C; Moum B; Vatn M; Stockbrugger R;
    Gastroenterology; 2006 Sep; 131(3):719-28. PubMed ID: 16952541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health Care Cost Analysis in a Population-based Inception Cohort of Inflammatory Bowel Disease Patients in the First Year of Diagnosis.
    Niewiadomski O; Studd C; Hair C; Wilson J; McNeill J; Knight R; Prewett E; Dabkowski P; Dowling D; Alexander S; Allen B; Tacey M; Connell W; Desmond P; Bell S
    J Crohns Colitis; 2015 Nov; 9(11):988-96. PubMed ID: 26129692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe--an ECCO-EpiCom study.
    Burisch J; Pedersen N; Cukovic-Cavka S; Turk N; Kaimakliotis I; Duricova D; Bortlik M; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Krabbe S; Andersen V; Dahlerup JF; Kjeldsen J; Salupere R; Olsen J; Nielsen KR; Manninen P; Collin P; Katsanos KH; Tsianos EV; Ladefoged K; Lakatos L; Ragnarsson G; Björnsson E; Bailey Y; O'Morain C; Schwartz D; Odes S; Giannotta M; Girardin G; Kiudelis G; Kupcinskas L; Turcan S; Barros L; Magro F; Lazar D; Goldis A; Nikulina I; Belousova E; Martinez-Ares D; Hernandez V; Almer S; Zhulina Y; Halfvarson J; Arebi N; Tsai HH; Sebastian S; Lakatos PL; Langholz E; Munkholm P;
    J Crohns Colitis; 2014 Jul; 8(7):607-16. PubMed ID: 24315795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health care and patients' education in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom study.
    Burisch J; Vegh Z; Pedersen N; Cuković-Čavka S; Turk N; Kaimakliotis I; Duricova D; Bortlik M; Shonová O; Thorsgaard N; Krabbe S; Andersen V; Dahlerup JF; Kjeldsen J; Salupere R; Olsen J; Nielsen KR; Manninen P; Collin P; Katsanos KH; Tsianos EV; Ladefoged K; Ragnarsson G; Björnsson E; Bailey Y; O'Morain C; Schwartz D; Odes S; Politi P; Santini A; Kiudelis G; Kupcinskas L; Turcan S; Magro F; Barros L; Lazar D; Goldis A; Nikulina I; Belousova E; Sanromán L; Martinez-Ares D; Almer S; Zhulina Y; Halfvarson J; Arebi N; Houston Y; Sebastian S; Langholz E; Lakatos PL; Munkholm P;
    J Crohns Colitis; 2014 Aug; 8(8):811-8. PubMed ID: 24439390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct and Indirect Costs of Inflammatory Bowel Disease: Ten Years of Follow-up in a Danish Population-based Inception Cohort.
    Lo B; Vind I; Vester-Andersen MK; Bendtsen F; Burisch J
    J Crohns Colitis; 2020 Jan; 14(1):53-63. PubMed ID: 31076743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing the long term care of inflammatory bowel disease patients: The cost to European health care providers.
    Buchanan J; Wordsworth S; Ahmad T; Perrin A; Vermeire S; Sans M; Taylor J; Jewell D
    J Crohns Colitis; 2011 Aug; 5(4):301-16. PubMed ID: 21683300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs of inflammatory bowel disease in Germany.
    Stark R; König HH; Leidl R
    Pharmacoeconomics; 2006; 24(8):797-814. PubMed ID: 16898849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher levels of knowledge reduce health care costs in patients with inflammatory bowel disease.
    Colombara F; Martinato M; Girardin G; Gregori D
    Inflamm Bowel Dis; 2015 Mar; 21(3):615-22. PubMed ID: 25636120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Evolution of Health Care Utilisation and Costs for Inflammatory Bowel Disease Over Ten Years.
    Pillai N; Dusheiko M; Maillard MH; Rogler G; Brüngger B; Bähler C; Pittet VEH;
    J Crohns Colitis; 2019 May; 13(6):744-754. PubMed ID: 30916775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
    Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV;
    Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and phenotype at diagnosis of inflammatory bowel disease. Results in Spain of the EpiCom study.
    Fernández A; Hernández V; Martínez-Ares D; Sanromán L; de Castro ML; Pineda JR; Carmona A; González-Portela C; Salgado C; Martínez-Cadilla J; Pereira S; García-Burriel JI; Vázquez S; Rodríguez-Prada I;
    Gastroenterol Hepatol; 2015 Nov; 38(9):534-40. PubMed ID: 25890448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.